ARCHIVES

PSA Velocity Poor Predictor Of Prostate Cancer Occurrence

This article is from The Cancer Letter archive.

Vol. 34 No. 3 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

Fraumeni Appointed field Studies Chief

January 18, 1980

Cancer Groups Fear Clinical Trials Coverage Will Not Be Implemented Across Exchanges

July 3, 2013

Cyramza-Docetaxel Combination Extends OS In Second-Line NSCLC

June 27, 2014

Frelick To Receive ACCC Annual Award Will Leave NCI In July

March 6, 1987

Retrospective Data Clean-Up Can’t Help C225 Phase II Trial; Protocol Far Too “Fuzzy”.

February 15, 2002

Spending Measures Include Provisions On Ethics For NIH Extramural Scientists.

July 11, 2008